Otoacoustic emission testing in Ghanaian children with sickle-cell disease

Josua Kegele1, Helene Hurth1, Peter Lackner1

  • 1Department of Neurology, NICU, Medical University Innsbruck, Innsbruck, Austria.

Insights

Hearing loss is not a common complication in children with sickle-cell disease (SCD). This study found no significant difference in hearing function between children with SCD and healthy controls.

Area of Science:

  • Pediatric Otolaryngology
  • Hematology
  • Genetics

Background:

  • Sickle-cell disease (SCD) is a genetic blood disorder with various potential complications.
  • Hearing impairment can be a complication of chronic illnesses, necessitating evaluation in pediatric SCD patients.

Purpose of the Study:

  • To assess the prevalence of hearing loss in children diagnosed with sickle-cell disease.
  • To determine if hearing impairment is a significant complication in pediatric SCD patients.

Main Methods:

  • Transient-evoked otoacoustic emissions (TEOAE) testing was performed on 35 children with SCD (ages 6 months to 10 years) in Kumasi, Ghana.
  • A control group of healthy Ghanaian children from school and kindergarten settings was recruited for comparison.

Main Results:

  • One child with SCD (2.9%) and 13 control children (11.3%) failed the TEOAE testing.
  • The observed difference in TEOAE failure rates between the SCD group and the control group was not statistically significant.

Conclusions:

  • Early-onset hearing impairment is not a regular occurrence in children with sickle-cell disease.
  • Hearing loss is unlikely to be a primary cause of delayed or impaired language development in pediatric SCD patients.
Abstract